FINANCIAL CONSULATE, INC

Position in JNJ — Johnson & Johnson

CIK 1624510 HUNT VALLEY, MD

Position in JNJ

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$931,307

+$69,901 QoQ

Shares Held

3,667

+4.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.71%

of 13F equity value

Holder Rank

#3,081

of 4,676 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 78% Shared 0% None 22%

Healthcare · as of Jun 30, 2026

FINANCIAL CONSULATE, INC holds $4,839,565 across 15 Drug Manufacturers - General names. JNJ ranks #3 (19.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,232	$1,477,697
2	MRK	Merck & Co., Inc.	7,599	$976,471
3	JNJ	Johnson & Johnson This page	3,667	$931,307
4	ABBV	AbbVie Inc.	3,167	$796,943
5	AZN	Astrazeneca PLC	870	$164,969
6	AMGN	Amgen Inc	445	$161,143
7	BMY	Bristol Myers Squibb Co	1,572	$90,578
8	NVS	Novartis AG	515	$80,710

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$931,307	3,667	+4.1%	Shares	Sole	2026-07-23
2026-03-31	$861,406	3,524	+5.0%	Shares	Sole	2026-04-21
2025-12-31	$694,317	3,355	-0.3%	Shares	Sole	2026-01-22
2025-09-30	$623,752	3,364	+1.8%	Shares	Sole	2025-10-21
2023-03-31	$511,965	3,303	-16.0%	Shares	Other	2023-04-17
2022-12-31	$694,764	3,933	-0.8%	Shares	Other	2023-01-11
2022-09-30	$647,395	3,963	0.0%	Shares	Other	2022-10-20
2022-06-30	$703,472	3,963	-27.7%	Shares	Other	2022-07-19
2022-03-31	$971,574	5,482	-4.2%	Shares	Other	2022-04-28
2021-12-31	$978,691	5,721	+16.4%	Shares	Sole	2022-02-07
2021-09-30	$793,934	4,916	-3.9%	Shares	Other	2021-10-19
2021-06-30	$842,645	5,115	0.0%	Shares	Other	2021-07-22
2021-03-31	$840,650	5,115	-2.8%	Shares	Other	2021-04-19
2020-12-31	$828,290	5,263	+8.8%	Shares	Other	2021-01-29
2020-09-30	$720,281	4,838	-0.8%	Shares	Other	2020-10-20
2020-06-30	$685,993	4,878	+25.9%	Shares	Other	2020-07-22
2020-03-31	$508,128	3,875	—	Shares	Other	2020-04-29
No filing history on record for this holder in this stock.